| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |